SUMER JACQUELYN L 4
4 · Cullinan Oncology, Inc. · Filed Aug 16, 2022
Insider Transaction Report
Form 4
SUMER JACQUELYN L
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-15+190,000→ 190,000 totalExercise: $14.16Exp: 2032-08-14→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 190,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on August 15, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.